Business Trip
Podcast készítő Greg Kubin & Matias Serebrinsky - Csütörtökök
59 Epizód
-
The state of psychedelics: Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
Közzétéve: 2022. 06. 05. -
Empowering the next wave of psychedelic therapists: Journey Clinical
Közzétéve: 2022. 05. 23. -
Osmind and the future of electronic health records in psychedelic medicine
Közzétéve: 2022. 04. 18. -
Palo Santo on investing in 2nd gen psychedelics and public markets
Közzétéve: 2022. 03. 21. -
Designing psychedelic mindstates, with Mindstate Design Labs
Közzétéve: 2022. 02. 10. -
PsyMed Ventures, our venture fund to invest in psychedelic medicine & mental health tech
Közzétéve: 2022. 01. 10. -
MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy
Közzétéve: 2021. 11. 24. -
On transformational ketamine therapy and running an integrative psychedelic clinic
Közzétéve: 2021. 10. 28. -
The new frontiers of DMT therapies
Közzétéve: 2021. 10. 06. -
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
Közzétéve: 2021. 08. 13. -
Analyzing the atai Life Sciences IPO
Közzétéve: 2021. 06. 10. -
A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
Közzétéve: 2021. 05. 04. -
Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney
Közzétéve: 2021. 03. 16. -
How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka
Közzétéve: 2021. 02. 24. -
From serving medicine to company founder: NANA founder Flor Bollini
Közzétéve: 2021. 01. 05. -
Helping psychedelic practitioners through software: Maya Health CEO David Champion
Közzétéve: 2020. 10. 19. -
How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer
Közzétéve: 2020. 09. 17. -
Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin
Közzétéve: 2020. 08. 13. -
Dylan Beynon: ketamine-assisted therapy for anxiety and depression
Közzétéve: 2020. 06. 21.
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
